Abstract | BACKGROUND: METHOD: RESULTS: CONCLUSION:
Tartrazine allergy should be considered in patients developing drug allergy, because it would require changing the brand rather than stopping treatment with that drug.
|
Authors | M S Bhatia |
Journal | The Journal of clinical psychiatry
(J Clin Psychiatry)
Vol. 61
Issue 7
Pg. 473-6
(Jul 2000)
ISSN: 0160-6689 [Print] United States |
PMID | 10937604
(Publication Type: Journal Article)
|
Chemical References |
- Flavoring Agents
- Food Coloring Agents
- Psychotropic Drugs
- Tartrazine
|
Topics |
- Adolescent
- Adult
- Drug Compounding
(adverse effects)
- Drug Hypersensitivity
(etiology)
- Female
- Flavoring Agents
(adverse effects)
- Food Coloring Agents
(adverse effects)
- Humans
- Male
- Mental Disorders
(drug therapy)
- Middle Aged
- Psychotropic Drugs
(adverse effects, therapeutic use)
- Tartrazine
(adverse effects, therapeutic use)
|